MARC보기
LDR03934cmm uu200685Ia 4500
001000000299904
003OCoLC
00520230517133732
006m d
007cr cnu---unuuu
008110816s2011 dcua ob 100 0 eng d
019 ▼a 741455473
020 ▼a 9780309163224 (electronic bk.)
020 ▼a 0309163226 (electronic bk.)
020 ▼a 9786613151735
020 ▼a 6613151734
020 ▼z 0309163218
020 ▼z 9780309163217
035 ▼a (OCoLC)746945424
040 ▼a N$T ▼b eng ▼c N$T ▼d IDEBK ▼d CDX ▼d NTE ▼d ORU ▼d OCLCQ ▼d E7B ▼d 248032
043 ▼a n-us---
049 ▼a K4RA
050 4 ▼a R857.N34 ▼b N375 2011eb
060 4 ▼a QZ 200
072 7 ▼a MED ▼x 003040 ▼2 bisacsh
072 7 ▼a MED ▼x 009000 ▼2 bisacsh
072 7 ▼a MED ▼x 029000 ▼2 bisacsh
072 7 ▼a MED ▼x 048000 ▼2 bisacsh
072 7 ▼a TEC ▼x 059000 ▼2 bisacsh
08204 ▼a 610.28 ▼2 23
24500 ▼a Nanotechnology and oncology ▼h [electronic resource] : ▼b workshop summary / ▼c Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.
260 ▼a Washington, D.C. : ▼b National Academies Press, ▼c c2011.
300 ▼a 1 online resource (xii, 106 p.) : ▼b ill.
504 ▼a Includes bibliographical references (p. 69-71).
520 ▼a "One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website.
588 ▼a Description based on print version record.
650 0 ▼a Nanomedicine ▼v Congresses.
650 0 ▼a Oncology ▼x Research ▼z United States ▼v Congresses.
650 0 ▼a Nanotechnology ▼v Congresses.
650 0 ▼a Cancer ▼x Treatment ▼v Congresses.
65012 ▼a Neoplasms ▼x therapy ▼v Congresses.
65022 ▼a Nanomedicine ▼v Congresses.
65022 ▼a Nanotechnology ▼v Congresses.
650 7 ▼a MEDICAL ▼x Allied Health Services ▼x Medical Technology. ▼2 bisacsh
650 7 ▼a MEDICAL ▼x Biotechnology. ▼2 bisacsh
650 7 ▼a MEDICAL ▼x Family & General Practice. ▼2 bisacsh
650 7 ▼a MEDICAL ▼x Lasers in Medicine. ▼2 bisacsh
650 7 ▼a TECHNOLOGY & ENGINEERING ▼x Biomedical. ▼2 bisacsh
655 4 ▼a Electronic books.
7001 ▼a Patlak, Margie.
7001 ▼a Micheel, Christine.
7102 ▼a Institute of Medicine (U.S.). ▼b Planning Committee on Policy Issues in Nanotechnology and Oncology.
7102 ▼a National Cancer Policy Forum (U.S.)
77608 ▼i Print version: ▼t Nanotechnology and oncology. ▼d Washington, D.C. : National Academies Press, c2011 ▼z 0309163218 ▼w (OCoLC)705518868
85640 ▼3 EBSCOhost ▼u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=375279
938 ▼a Ingram Digital eBook Collection ▼b IDEB ▼n 315173
938 ▼a Coutts Information Services ▼b COUT ▼n 18113815
938 ▼a ebrary ▼b EBRY ▼n ebr10495452
990 ▼a 관리자
994 ▼a 92 ▼b K4R